Bioharvest Sciences (BHST) Cost of Revenue (2023 - 2025)

Bioharvest Sciences' Cost of Revenue history runs 3 years deep, the most recent figure standing at $3.8 million for Q4 2025.

• In Q4 2025, Cost of Revenue rose 5.46% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $14.0 million (up 19.59% YoY), while the FY2025 annual figure was $14.0 million, up 19.59% from the prior year.
• Cost of Revenue for Q4 2025 stood at $3.8 million, up from $3.5 million in the prior quarter.
• The five-year high for Cost of Revenue was $3.8 million in Q4 2025, with the low at $1.6 million in Q2 2023.
• The 3-year median for Cost of Revenue is $2.9 million (2024), against an average of $2.9 million.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue surged 77.92% in 2024, then increased 5.46% in 2025.
• Bioharvest Sciences' Cost of Revenue stood at $2.2 million in 2023, then surged by 63.54% to $3.6 million in 2024, then gained by 5.46% to $3.8 million in 2025.
• Business Quant data shows BHST's Cost of Revenue at $3.8 million in Q4 2025, $3.5 million in Q3 2025, and $3.4 million in Q2 2025.